{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:34:49Z","timestamp":1757540089182},"reference-count":65,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity"],"published-print":{"date-parts":[[1989,1]]},"DOI":"10.3109\/08916938908997101","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T18:40:04Z","timestamp":1260211204000},"page":"307-315","source":"Crossref","is-referenced-by-count":11,"title":["High dose Intravenous Gammaglobulins in Autoimmune Disorders: Mode of action and Therapeutic Uses"],"prefix":"10.1080","volume":"3","author":[{"given":"Amos","family":"Etzioni","sequence":"first","affiliation":[{"name":"Division of Clinical Immunology, Rambam Medical Center, and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Pollack","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology, Rambam Medical Center, and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"23","article-title":"Requirements for modern intravenous immunoglobulin preparations and their safe clinical use","volume":"26","author":"Hassig A","year":"1987","unstructured":"Hassig A. Requirements for modern intravenous immunoglobulin preparations and their safe clinical use. Triangle 1987; 26: 23\u201332","journal-title":"Triangle"},{"key":"e_1_2_1_3_1","first-page":"27","volume-title":"Clinical Use of Intravenous Immunoglobulin","author":"Colomb M G","year":"1986","unstructured":"Colomb M G, Drauet C, Law D TS, Painter R H. Structural and biological properties of three intravenous immunoglobulin preparations. Clinical Use of Intravenous Immunoglobulin, A Morell, U E Nydegger. Academic Press, London 1986; 27\u201336"},{"key":"e_1_2_1_4_1","first-page":"89","article-title":"Intravenous immunoglobulin: new clinical applications","volume":"60","author":"Steele R W","year":"1988","unstructured":"Steele R W, Burks W, Jr., Williams L W. Intravenous immunoglobulin: new clinical applications. Ann Allergy 1988; 60: 89\u201394","journal-title":"Ann Allergy"},{"key":"e_1_2_1_5_1","first-page":"417","article-title":"IUIS\/WHO Notice","volume":"52","author":"Appropriate use of human immunoglobulin in clinical practice","year":"1983","unstructured":"Appropriate use of human immunoglobulin in clinical practice. IUIS\/WHO Notice. Clin Exp Immunol 1983; 52: 417\u201322","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_6_1","first-page":"140","article-title":"Clinical uses of intravenous immunoglobulins","volume":"25","author":"Berkman S A","year":"1988","unstructured":"Berkman S A, Lee M L, Gale K P. Clinical uses of intravenous immunoglobulins. Sem Hemat 1988; 25: 140\u201358","journal-title":"Sem Hemat"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198602273140907"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91506-X"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90496-8"},{"key":"e_1_2_1_10_1","first-page":"254","article-title":"Possible transmission of non-A, non-B hepatitis","volume":"51","author":"Lockburn I","year":"1986","unstructured":"Lockburn I. Possible transmission of non-A, non-B hepatitis. Vox Sang 1986; 51: 254","journal-title":"Vox Sang"},{"key":"e_1_2_1_11_1","first-page":"6","article-title":"Non-A, Non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: A retrospective survey","volume":"54","author":"Rousell R H","year":"1988","unstructured":"Rousell R H, Good R A, Pirofsky B, Schiff R I. Non-A, Non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: A retrospective survey. Vox Sang 1988; 54: 6\u201313","journal-title":"Vox Sang"},{"key":"e_1_2_1_12_1","first-page":"231","article-title":"Safety of therapeutic immune globulin preparations with respect to transmission of HTLV-III\/LAV infection","volume":"35","year":"1986","unstructured":"Safety of therapeutic immune globulin preparations with respect to transmission of HTLV-III\/LAV infection. MMWR 1986; 35: 231\u20133","journal-title":"MMWR"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(84)91376-X","article-title":"Intravenous immune globulin: A cautionary note","volume":"1","author":"Cross A S","year":"1984","unstructured":"Cross A S, Alving B M, Sadoff J C, Baldwin P, Terebelo H, Tong D. Intravenous immune globulin: A cautionary note. Lancet 1984; 1: 912","journal-title":"Lancet"},{"key":"e_1_2_1_14_1","first-page":"31","volume-title":"Immunoglobulins: Characteristics and Uses of Intravenous Preparations","author":"Barandun S","year":"1980","unstructured":"Barandun S, Morell A, Skvaril F. Clinical experiences with immunoglobulin for intravenous use. Immunoglobulins: Characteristics and Uses of Intravenous Preparations, B M Alving, J S Finlayson. U.S. Dept. Health Human Services. 1980; 31\u20135, CFDA-80\u20139005"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92400-4"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90547-X"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(87)90546-8","article-title":"Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gammaglobulin in the treatment of immune thrombocytopenic purpura in adults","volume":"84","author":"Kurlander R","year":"1987","unstructured":"Kurlander R, Coleman R E, Moore J, Gockerman J, Rosse W, Siegal R. Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gammaglobulin in the treatment of immune thrombocytopenic purpura in adults. Amer J Med 1987; 84: 17\u201324, supp 4A","journal-title":"Amer J Med"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710153171606"},{"key":"e_1_2_1_19_1","first-page":"885","article-title":"Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin","volume":"106","author":"Bussell J B","year":"1985","unstructured":"Bussell J B, Goldman A, Imbach P, Schulman I, Hilgartner M W. Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin. J Pediat 1985; 106: 885\u201390","journal-title":"J Pediat"},{"key":"e_1_2_1_20_1","first-page":"203","volume-title":"Clinical Use of Intravenous Immunoglobulins","author":"Newland A C","year":"1986","unstructured":"Newland A C. Intravenous immunoglobulin therapy in chronic idiopathic thrombocytopenia purpura. Clinical Use of Intravenous Immunoglobulins, A Morrell, U E Nydegger. Academic Press, London 1986; 203\u201316"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3476(88)80705-4","article-title":"High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia","volume":"112","author":"Ballin A","year":"1988","unstructured":"Ballin A, Andrew M, Ling E, Perlman M, Blanchette V. High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediat 1988; 112: 189\u201392","journal-title":"J Pediat"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91738-5"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7326\/0003-4819-104-6-808","article-title":"Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion","volume":"104","author":"Baumann M A","year":"1986","unstructured":"Baumann M A, Manitove J E, Aster R H, Anderson T. Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion. Ann Inter Med 1986; 104: 808\u20139","journal-title":"Ann Inter Med"},{"key":"e_1_2_1_24_1","first-page":"1151","article-title":"Gammaglobulin for idiopathic thrombocytopenic purpura","volume":"307","author":"Cohen J I","year":"1982","unstructured":"Cohen J I. Gammaglobulin for idiopathic thrombocytopenic purpura. New Eng J Med 1982; 307: 1151","journal-title":"New Eng J Med"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80163-X"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80878-2"},{"key":"e_1_2_1_27_1","first-page":"291","article-title":"Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)","volume":"59","author":"Lin C","year":"1987","unstructured":"Lin C, Hwang Y. B. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease). Ann Allergy 1987; 59: 291\u20137","journal-title":"Ann Allergy"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608073150601"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80007-0"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(87)80269-X","article-title":"Kawasaki disease: clinical prospective","volume":"111","author":"Bierman F Z","year":"1987","unstructured":"Bierman F Z, Gersony W M. Kawasaki disease: clinical prospective. J Pediat 1987; 111: 789\u201392","journal-title":"J Pediat"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112835"},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM198207223070420","article-title":"Cunningham-Rundles C, Smithwick EM, Barandun S, Good RA. High-dose intravenous gammaglobulin for autoimmune neutropenia","volume":"307","author":"Pollack S","year":"1982","unstructured":"Pollack S. Cunningham-Rundles C, Smithwick EM, Barandun S, Good RA. High-dose intravenous gammaglobulin for autoimmune neutropenia. New Eng J Med 1982; 307: 253","journal-title":"New Eng J Med"},{"key":"e_1_2_1_33_1","first-page":"702","article-title":"High dose intravenous \u03b3-globulin for Felt's syndrome","volume":"12","author":"Breedveld F C","year":"1985","unstructured":"Breedveld F C, Brand A, Van Aken W G. High dose intravenous \u03b3-globulin for Felt's syndrome. J Rheumatol 1985; 12: 702\u20137","journal-title":"J Rheumatol"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80074-X"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07430.x"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1986.tb01967.x"},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2141.1983.tb01260.x","article-title":"Treatment of pure red cell aplasia by high dose intravenous immunoglobulin","volume":"56","author":"Clauvel J P","year":"1983","unstructured":"Clauvel J P, Vainchenker W, Herrera A, Dellagi K, Uinci G, Tabilio A, Lacombe C. Treatment of pure red cell aplasia by high dose intravenous immunoglobulin. Brit J Haemat 1983; 56: 380\u20132","journal-title":"Brit J Haemat"},{"key":"e_1_2_1_38_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajh.2830220410","article-title":"Intramuscular gammaglobulin therapy in a child with hypoparathyroidism and pure red cell aplasia","volume":"16","author":"Etzioni A","year":"1986","unstructured":"Etzioni A, Atias D, Pollack S, Hazani A, Vardi P, Levy J, Benderly A. Intramuscular gammaglobulin therapy in a child with hypoparathyroidism and pure red cell aplasia. Amer J hematol 1986; 16: 409\u201314","journal-title":"Amer J hematol"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370120101017"},{"key":"e_1_2_1_40_1","volume-title":"XII International Congress of Allergology and Clinical Immunology","author":"Etzioni A","unstructured":"Etzioni A, Hazani A, Pollack S, Erde P, Benderly A. High dose intravenous gammaglobulin in a child with recurrent hemolytic-uremic syndrome. XII International Congress of Allergology and Clinical Immunology, MontreuxSwitzerland, 1988"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00319971"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.3.828"},{"key":"e_1_2_1_43_1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archinte.1986.00360190143020","article-title":"High-dose intravenous immunoglobulin in the management of myastenia gravis","volume":"146","author":"Arzura E L","year":"1986","unstructured":"Arzura E L, Bick A, Brunner N G, Namba T, Grob D. High-dose intravenous immunoglobulin in the management of myastenia gravis. Arch Intern Med 1986; 146: 1365\u20138","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915153"},{"key":"e_1_2_1_45_1","volume-title":"Immunointervention in autoimmune disease","author":"Liblau R","year":"1988","unstructured":"Liblau R, Gajdos P, Bustarret A F, el-Habib R, Bach J F, Morel E. The use of intravenous gammaglobulin in myastenia gravis; interaction with myastenic sera. Immunointervention in autoimmune disease. Paris June, 16\u201319, 1988"},{"key":"e_1_2_1_46_1","first-page":"964","article-title":"Bullous pemphigoid and intravenous gammaglobulin","volume":"103","author":"Godard W","year":"1986","unstructured":"Godard W, Roujeau J C, Guillot B, Andre C, Rifle G. Bullous pemphigoid and intravenous gammaglobulin. Ann Inter Med 1986; 103: 964\u20135","journal-title":"Ann Inter Med"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00319968"},{"key":"e_1_2_1_48_1","volume-title":"Immunointervention in Autoimmune Disease","author":"Pedersen F K","year":"1988","unstructured":"Pedersen F K. Systemic juvenile rheumatoid arthritis treated with intravenous immunoglobulin. Immunointervention in Autoimmune Disease. Paris June, 16\u201319, 1988"},{"key":"e_1_2_1_49_1","first-page":"446A","article-title":"Treatment of systemic juvenile arthritis with intravenous serum gammaglobulin","volume":"36","author":"Roifman C M","year":"1988","unstructured":"Roifman C M, Laxer R M, Gelfand E W, Silverman I J. Treatment of systemic juvenile arthritis with intravenous serum gammaglobulin. Clin Res 1988; 36: 446A","journal-title":"Clin Res"},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1651-2227.1985.tb11039.x","article-title":"Gammaglobulin therapy in 6 newly diagnosed diabetic children","volume":"74","author":"Heinze E","year":"1985","unstructured":"Heinze E, Thon A, Vetter U, Gaedicke G, Zuppinger K. Gammaglobulin therapy in 6 newly diagnosed diabetic children. Acta Paediat Scand 1985; 74: 605\u20136","journal-title":"Acta Paediat Scand"},{"key":"e_1_2_1_51_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(83)90144-7","article-title":"High dose gammaglobulin for intractable childhood epilepsy","volume":"2","author":"Ariizumi M","year":"1983","unstructured":"Ariizumi M, Bala K, Shiihara H. High dose gammaglobulin for intractable childhood epilepsy. Lancet 1983; 2: 162\u20133","journal-title":"Lancet"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198205273062102"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V62.2.480.480"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90175-7"},{"key":"e_1_2_1_55_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4049\/jimmunol.132.2.745","article-title":"Modulation of mononuclear phagocyte function by intravenous gammaglobulin","volume":"132","author":"Kimberly R P","year":"1984","unstructured":"Kimberly R P, Salmon J E, Bussel J B, Crow M K, Hilgartner M W. Modulation of mononuclear phagocyte function by intravenous gammaglobulin. J Immunol 1984; 132: 745\u201350","journal-title":"J Immunol"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915364"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.132.6.1279"},{"key":"e_1_2_1_58_1","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4049\/jimmunol.136.12.4407","article-title":"Cellular mechanisms in the in vitro inhibition of pokeweed mitogen induced B cell differentiation by immunoglobulin for intravenous use","volume":"136","author":"Stohl W","year":"1986","unstructured":"Stohl W. Cellular mechanisms in the in vitro inhibition of pokeweed mitogen induced B cell differentiation by immunoglobulin for intravenous use. J Immunol 1986; 136: 1407\u201313","journal-title":"J Immunol"},{"key":"e_1_2_1_59_1","first-page":"431","volume-title":"Clinical Use of Intravenous Immunoglobulin","author":"Nydegger U E","year":"1986","unstructured":"Nydegger U E, Spycher M O. Polyclonal polyspecific antibody mixtures from random donors as therapeutic tools in autoimmune disease. Clinical Use of Intravenous Immunoglobulin, A Morrell, U E Nydegger. Academic Press, London 1986; 431\u201341"},{"key":"e_1_2_1_60_1","first-page":"697","article-title":"Alteration of T cell subsets and immunoglobulin synthesis in vitro during high-dose gammaglobulin therapy in patients with idiopathic thrombocytopenic purpura","volume":"53","author":"Tsubakio T","year":"1983","unstructured":"Tsubakio T, Kurata Y, Katagiri Sand. Alteration of T cell subsets and immunoglobulin synthesis in vitro during high-dose gammaglobulin therapy in patients with idiopathic thrombocytopenic purpura. Clin Exp Immunol 1983; 53: 697\u2013702","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_61_1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0002-9343(87)90752-2","article-title":"Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia","volume":"83","author":"White W B","year":"1987","unstructured":"White W B, Desbonnet C R, Ballow M. Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia. Amer J Med 1987; 83: 431\u20136","journal-title":"Amer J Med"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07417.x"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90701-3"},{"key":"e_1_2_1_64_1","first-page":"133","article-title":"Selected pathophysiological aspects of autoimmune disease as the basis for transfusion therapy with polyclonal antibody mixtures","volume":"23","author":"Nydegger U E","year":"1984","unstructured":"Nydegger U E. Selected pathophysiological aspects of autoimmune disease as the basis for transfusion therapy with polyclonal antibody mixtures. Triangle 1984; 23: 133\u201340","journal-title":"Triangle"},{"key":"e_1_2_1_65_1","volume-title":"Immunointervention in Autoimmune Disease","author":"Rossi F","year":"1988","unstructured":"Rossi F, Brand A, Kazachkine M D. Anti-idiotypic suppression of autoantibodies with polyspecific normal immunoglobulins. Immunointervention in Autoimmune Disease. ParisFrance 1988"},{"key":"e_1_2_1_66_1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJM198804143181514","article-title":"Gammaglobulin for antibody mediated pure red cell aplasia","volume":"318","author":"Etzioni A","year":"1988","unstructured":"Etzioni A, Pollack S, Benderly A. Gammaglobulin for antibody mediated pure red cell aplasia. New Eng J Med 1988; 318: 994","journal-title":"New Eng J Med"}],"container-title":["Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/08916938908997101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:15:30Z","timestamp":1720617330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/08916938908997101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["10.3109\/08916938908997101"],"URL":"https:\/\/doi.org\/10.3109\/08916938908997101","relation":{},"ISSN":["0891-6934","1607-842X"],"issn-type":[{"value":"0891-6934","type":"print"},{"value":"1607-842X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}